Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity

Walton, Josephine B.Farquharson, MalcolmMason, SusanPort, JenniferKruspig, BjornDowson, SuzanneStevenson, DavidMurphy, DanielMatzuk, MartinKim, JaeyeonCoffelt, SethBlyth, KarenMcNeish, Iain A.2018-08-022018-08-022018-04-13Walton, J. B., Farquharson, M., Mason, S., Port, J., Kruspig, B., Dowson, S., … McNeish, I. A. (2018). Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. Scientific Reports, 8, 6231. http://doi.org/10.1038/s41598-018-24099-3https://hdl.handle.net/1805/16960A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.en-USAttribution 3.0 United StatesChemotherapyCarcinomaOvarian cancerCRISPRAuthor Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivityArticle